Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, et al.
European Neuropsychopharmacology (2020) Vol. 33, pp. 71-80
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David Nutt, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 101-118
Closed Access | Times Cited: 256
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 184
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 156
Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses
Drummond E-Wen McCulloch, Gitte M. Knudsen, Frederick S. Barrett, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104689-104689
Open Access | Times Cited: 77
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 44
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity
M. Madsen, Anja Sofie Petersen, Dea Siggaard Stenbæk, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 1, pp. 55-67
Closed Access | Times Cited: 16
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial
Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 114-125
Closed Access | Times Cited: 2
Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions
Namik Kirlić, Molly Lennard-Jones, Merve Atli, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 126-132
Closed Access | Times Cited: 2
Pivotal mental states
Ari Brouwer, Robin Carhart‐Harris
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 319-352
Open Access | Times Cited: 112
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
M. Madsen, Dea Siggaard Stenbæk, Albin Arvidsson, et al.
European Neuropsychopharmacology (2021) Vol. 50, pp. 121-132
Open Access | Times Cited: 92
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
Albert Garcia‐Romeu, Frederick S. Barrett, Theresa M. Carbonaro, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 353-361
Open Access | Times Cited: 72
Dose–response relationships of psilocybin-induced subjective experiences in humans
Tim Hirschfeld, Timo Torsten Schmidt
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 384-397
Open Access | Times Cited: 67
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
Drummond E-Wen McCulloch, Maria Zofia Grzywacz, Martin Bruun Madsen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 54
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
Sustained effects of single doses of classical psychedelics in humans
Gitte M. Knudsen
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 145-150
Open Access | Times Cited: 39
Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
Consciousness and Cognition (2023) Vol. 110, pp. 103494-103494
Open Access | Times Cited: 28
Effects of DMT on mental health outcomes in healthy volunteers
Christopher Timmermann, Richard J. Zeifman, David Erritzøe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Psychedelics and sexual functioning: a mixed-methods study
Tommaso Barba, Hannes Kettner, Caterina Radu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression
David Erritzøe, Tommaso Barba, Meg J. Spriggs, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 458-470
Open Access | Times Cited: 8
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, et al.
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 459-468
Closed Access | Times Cited: 65
Psychedelics and Psychotherapy
Sandeep M. Nayak, Matthew W. Johnson
Pharmacopsychiatry (2020) Vol. 54, Iss. 04, pp. 167-175
Closed Access | Times Cited: 53
Page 1 - Next Page

Scroll to top